Device to allow MRI measurements of tumor oxygen levels

| | Health Imaging | Oncology Imaging

The ability to measure a tumor’s oxygen levels could help guide treatment decisions, and now, for the first time, a method to reliably and noninvasively take such measurements could soon be available. A team of researchers at the Massachusetts Institute of Technology has developed an injectable device that can monitor oxygen levels long-term and be read with MRI.

Read more about the device at the link below:

Tracking oxygen in the body

Related Content

CT findings linked to heightened risk of pancreatic cancer recurrence
New research argues for MRI in all prostate cancer patients, even those considered low-risk
FAPI PET improves staging and clinical management for a significant portion of pancreatic cancers
Reducing prostate cancer treatment dosage alleviates downsides while remaining effective
Researchers score $2M to examine side effects of radiation therapy in prostate cancer patients
How much is too much when it comes to cryoablation volumes in solitary kidneys?

Around the web

Cardiovascular Business
Cath lab techs and nurses see new normal with post-COVID pay

In the post-COVID era, wages for permanent RNs are rising, and wages for travelers are decreasing. A new report tracked these trends and more. 

Radiology Business
The pros and cons of current breast screening modalities and the role of AI

Debra L. Monticciolo, MD, past president of both the Society of Breast Imaging and the American College of Radiology, explains the advantages and disadvantages of current breast screening technology.

Cardiovascular Business
ASE shares new guideline on imaging patients with implanted devices

The new guideline details the best imaging strategies for a variety of clinical scenarios. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup